279 related articles for article (PubMed ID: 12044582)
1. Statins and ischemic stroke.
Liao JK
Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
[TBL] [Abstract][Full Text] [Related]
2. Direct vascular effects of HMG-CoA reductase inhibitors.
Laufs U; Liao JK
Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
[TBL] [Abstract][Full Text] [Related]
3. Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production.
Davis ME; Harrison DG
Circulation; 2001 Jan; 103(1):2-4. PubMed ID: 11136674
[No Abstract] [Full Text] [Related]
4. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
5. The cardioprotective effects of statins.
Eto M; Lüscher TF
Coron Artery Dis; 2004 Aug; 15(5):243-5. PubMed ID: 15238819
[TBL] [Abstract][Full Text] [Related]
6. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
[TBL] [Abstract][Full Text] [Related]
8. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
9. Statins and endothelial dysfunction.
Larose E; Ganz P
Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
[TBL] [Abstract][Full Text] [Related]
10. Drug Insight: statins and stroke.
Sacco RL; Liao JK
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):576-84. PubMed ID: 16258569
[TBL] [Abstract][Full Text] [Related]
11. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
12. Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis.
Kalinowski L; Dobrucki IT; Malinski T
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):585-95. PubMed ID: 12512694
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide.
Ma S; Ma CC
Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660
[TBL] [Abstract][Full Text] [Related]
15. Prevention of stroke and dementia with statins: Effects beyond lipid lowering.
Vaughan CJ
Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295
[TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
Miida T; Hirayama S; Nakamura Y
J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
[TBL] [Abstract][Full Text] [Related]
18. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice.
Amin-Hanjani S; Stagliano NE; Yamada M; Huang PL; Liao JK; Moskowitz MA
Stroke; 2001 Apr; 32(4):980-6. PubMed ID: 11283400
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
Takemoto M; Liao JK
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455
[TBL] [Abstract][Full Text] [Related]
20. Statins and their role in vascular protection.
Mason JC
Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
